Intraarticular Tramadol-Bupivacaine Combination Prolongs the Duration of Postoperative Analgesia After Outpatient Arthroscopic Knee Surgery

BACKGROUND: Intraarticular (IA) local anesthetics are often used for the management and prevention of pain after arthroscopic knee surgery. Recently, IA tramadol was also used for the management of these patients. However, the IA combination of local anesthetic and tramadol has not been evaluated in arthroscopic outpatients. Our primary aim in this study was to evaluate the analgesic effect of an IA combination of bupivacaine and tramadol when compared with each drug alone using visual analog scale (VAS) pain scores in patients undergoing day-care arthroscopic knee surgery. Additionally, we assessed analgesic demand. METHODS: Ninety ASA I/II patients undergoing arthroscopic partial meniscectomy, performed by a single surgeon under general anesthesia, were assigned in a randomized, double-blind manner into three groups: group B (n = 30) received 0.25% bupivacaine, group T (n = 30) received 100 mg tramadol, and group BT (n = 30) received 0.25% bupivacaine and 100 mg tramadol to a total volume of 20 mL by the IA route after surgery. Postoperative pain scores were measured on a VAS, at rest and on mobilization at 0.5, 1, 2, 4, 6, 8, 12, and 24 h. Duration of analgesia, the subsequent 24 h consumption of rescue analgesia, time to ambulation, and time to discharge were evaluated. In addition, the systemic side effects of the IA injected drugs were also assessed. RESULTS: The results showed significantly lower VAS pain scores in group BT (P ≪ 0.1) when compared with groups T and B. Group BT had a later onset of postsurgical pain and longer time to first rescue analgesic than groups B and T. The 24 h consumption of analgesic was significantly less in group BT when compared with the other two groups (26.7% of the patients required rescue analgesia in group BT, whereas this number was 90% in group B and 86.7% in group T). In addition, time in hours to discharge and time to unassisted ambulation were significantly shorter in group BT when compared with groups T and B, and this was not associated with any detectable systemic effects. CONCLUSION: The IA admixture of tramadol 100 mg with bupivacaine 0.25% provides a pronounced prolongation of analgesia compared with either drug alone in patients undergoing day care arthroscopic knee surgery.

[1]  S. Kapral,et al.  Tramadol added to mepivacaine prolongs the duration of an axillary brachial plexus blockade. , 1999, Anesthesia and analgesia.

[2]  R. Mahajan,et al.  Bupivacaine/ketamine is superior to intra-articu-lar ketamine analgesia following arthroscopic knee surgery , 2005, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[3]  B. Boden,et al.  Analgesic effect of intraarticular morphine, bupivacaine, and morphine/bupivacaine after arthroscopic knee surgery. , 1994, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[4]  J. Nolan,et al.  Analgesia after day-case knee arthroscopy: double-blind study of intra-articular tenoxicam, intra-articular bupivacaine and placebo. , 1997, British journal of anaesthesia.

[5]  F. Turan,et al.  The use of intraarticular tramadol for postoperative analgesia after arthroscopic knee surgery: a comparison of different intraarticular and intravenous doses , 2004, Knee Surgery, Sports Traumatology, Arthroscopy.

[6]  E. Shipton.  Tramadol--present and future. , 2000, Anaesthesia and intensive care.

[7]  Shipton Ea.  Tramadol--present and future. , 2000 .

[8]  J. Besson,et al.  Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. , 1992, European journal of pharmacology.

[9]  G. Joshi,et al.  The Effect of Tourniquet Release Time on the Analgesic Efficacy of Intraarticular Morphine After Arthroscopic Knee Surgery , 1997, Anesthesia and analgesia.

[10]  J. Gerloff,et al.  Bioavailability of tramadol after i.m. injection in comparison to i.v. infusion. , 1999, International journal of clinical pharmacology and therapeutics.

[11]  A. Gasparetto,et al.  Ondansetron Inhibits the Analgesic Effects of Tramadol: A Possible 5-HT3 Spinal Receptor Involvement in Acute Pain in Humans , 2002, Anesthesia and analgesia.

[12]  R. Shank,et al.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. , 1992, The Journal of pharmacology and experimental therapeutics.

[13]  M. Guven,et al.  Differential Effects of Lidocaine and Tramadol on Modified Nerve Impulse by 4-Aminopyridine in Rats , 2003, Pharmacology.

[14]  A. Stubhaug,et al.  Electrical Nerve Stimulation or Ultrasound Guidance for Lateral Sagittal Infraclavicular Blocks: A Randomized, Controlled, Observer-Blinded, Comparative Study , 2008, Anesthesia and analgesia.

[15]  J. Stamford,et al.  Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. , 1997, British journal of anaesthesia.

[16]  N. Turan,et al.  Intraarticular analgesia after arthroscopic knee surgery: comparison of neostigmine, clonidine, tenoxicam, morphine and bupivacaine , 2005, Knee Surgery, Sports Traumatology, Arthroscopy.

[17]  G. Dautel,et al.  Tramadol Added to 1.5% Mepivacaine for Axillary Brachial Plexus Block Improves Postoperative Analgesia Dose-Dependently , 2004, Anesthesia and analgesia.

[18]  L. Radbruch,et al.  A Risk-Benefit Assessment of Tramadol in the Management of Pain , 1996, Drug safety.